M-590-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000387314.1(MT-TF):n.14A>G variant causes a non coding transcript exon change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Mitomap GenBank:
Absent
Consequence
MT-TF
ENST00000387314.1 non_coding_transcript_exon
ENST00000387314.1 non_coding_transcript_exon
Scores
Mitotip
Benign
Clinical Significance
EXIT+ataxia+RP
Conservation
PhyloP100: 8.18
Genes affected
MT-TF (HGNC:7481): (mitochondrially encoded tRNA phenylalanine)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
No frequency data in Mitomap. Probably very rare.
BP4
Mitotip and hmtvar scores support benign criterium.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRNF | TRNF.1 use as main transcript | n.14A>G | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MT-TF | ENST00000387314.1 | n.14A>G | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Gnomad homoplasmic
AF:
AC:
0
AN:
56433
Gnomad heteroplasmic
AF:
AC:
1
AN:
56433
Mitomap
EXIT+ataxia+RP
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Mitochondrial disease Pathogenic:1Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen | Jun 24, 2024 | The m.590A>G variant in MT-TF has been reported in one individual to date, in a woman with childhood onset mitochondrial myopathy. She had exercise intolerance, cerebellar ataxia, and retinitis pigmentosa. Muscle biopsy showed many ragged red fibers, 60% COX-negative fibers, and lipid overload. Respiratory chain enzyme activities were normal. The variant was present at 92% in muscle and was undetectable in blood, urine, and buccal sample. Haplogroup was H80 (PMID: 32419253). The variant was present at <5% in blood from her healthy mother and was undetectable in mother’s urine and buccal sample, and was undetectable in blood, buccal sample, and urine from her healthy sister. This cannot be considered evidence of de novo status as the variant was also undetectable in the proband’s blood. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). Single fiber testing showed higher levels of the variant in COX-negative fibers (89.10±9.3%; N = at least 10) than in COX-positive fibers (44.74±24.79%; N = at least 10), p<0.0001 (PS3_supporting, PMID: 32419253). The computational predictor MitoTIP suggests this variant is neutral (16.3 percentile) and HmtVAR predicts it to be polymorphic with a score of 0.05. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on June 24, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS3_supporting, PM2_supporting. - |
Pathogenic, no assertion criteria provided | in vitro | Medical Genetics, CHU Nice | Oct 01, 2019 | Static cerebellar ataxia, exercise intolerance, retinitis pigmentosa - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Benign
Hmtvar
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at